- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03315247
Tele-CBT Following Bariatric Surgery: Randomized Control Trial
May 8, 2024 updated by: Sanjeev Sockalingam, University Health Network, Toronto
Telephone-Based Cognitive Behavioural Therapy for Post-Operative Bariatric Surgery Patients: A Randomized Controlled Trial
Bariatric (weight loss) surgery is the most effective treatment for extreme obesity, but surgery does not treat underlying psychological and behavioural issues.
Currently, psychotherapy ("talk therapy") for eating problems is not routinely offered with surgery, and many people start to regain weight one year later.
Objective: This study will examine if adding a convenient and accessible psychotherapy by phone one year after surgery will lead to increased weight loss two years after surgery.
Primary Hypothesis: Relative to the Control group (who will get routine care), the group of individuals who get psychotherapy will have lower weights 2 years after surgery.
Secondary Hypotheses: Relative to the Control group, the psychotherapy group will report significantly less maladaptive eating behaviours and medical burden, and significantly greater quality of life.
Method: Participants recruited from the Bariatric Surgery Programs at Toronto Western Hospital will be randomly assigned to 1 of 2 groups: 1) Control (Usual Standard of Care) or 2) Tele-CBT (a 7-session telephone-based cognitive behavioural therapy [a type of "talk therapy"] intervention focused on developing coping skills to improve maladaptive thoughts, emotions, and eating behaviours, specifically designed for bariatric surgery patients, delivered 1 year post-surgery).
They will have their weight measured and will complete measures of eating behaviour and quality of life prior to the intervention, and again at several time points extending to 2 years post-surgery.
Implications: If Telephone-Cognitive Behavioural Therapy (CBT) is found to improve bariatric surgery outcomes, it could become the standard of care in Canadian bariatric surgery programs and beyond, and be routinely offered to patients who cannot feasibly attend CBT sessions due to physical or practical barriers.
Study Overview
Study Type
Interventional
Enrollment (Actual)
306
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T2S8
- Toronto Western Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Received bariatric surgery 1 year ago
- Fluent in English
- Have Internet access to complete online questionnaires.
Exclusion Criteria:
- Current active suicidal ideation
- Current poorly controlled psychiatric illness that would render Tele-CBT very difficult, including serious mental illness (i.e., psychotic disorder, bipolar disorder), severe depression (i.e., current major depressive episode diagnosis and Patient Health Questionnaire [PHQ-9]61 score > 20), or severe anxiety (i.e., current anxiety disorder diagnosis and Generalized Anxiety Disorder [GAD-7]62 score >15)
- Current poorly controlled medical illness that would render Tele-CBT very difficult.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Treatment as Usual
Participants assigned to the Treatment as Usual group will attend routine clinic visits at the Toronto Western Hospital Bariatrics Surgery Program (TWH-BSP).
These visits generally include education on bariatric surgery and nutrition.
Patients meet with select members of the multidisciplinary team at 1, 2, and 3 years post-surgery, and may attend an optional monthly support group.
Participants' service utilization (i.e., attendance at optional sessions) will be documented and compared across groups.
|
|
|
Experimental: Telephone-Based CBT
The Tele-CBT intervention will be delivered 1 year following bariatric surgery.
Participants will receive 6 weekly Telephone-based Cognitive Behavioural Therapy sessions and 1 final "booster" session 1 month later, all approximately 55-minutes in duration and scheduled at a time convenient for the participants.
|
The Tele-CBT sessions focus on introducing the cognitive behavioural model of overeating and obesity, scheduling healthy meals and snacks at regular time intervals and recording consumption using food records, scheduling pleasurable alternative activities to overeating, identifying and planning for difficult eating scenarios, and reducing vulnerability to overeating by solving problems and challenging negative thoughts.
Participants are expected to complete CBT homework between sessions, such as completing food records, engaging in pleasurable and self-care activities, and completing a variety of worksheets.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Weight
Time Frame: 1.25, 1.5, 2, 3 years post-surgery
|
Change in weight measured in kg
|
1.25, 1.5, 2, 3 years post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in obesity-related medical comorbidities - Medication Burden
Time Frame: 2 and 3 years post-surgery
|
Medication pill burden/Type 2 Diabetes Mellitus (T2DM) specific medication burden
|
2 and 3 years post-surgery
|
|
Changes in obesity-related medical comorbidities - Medical Treatments
Time Frame: 2 and 3 years post-surgery
|
Discontinuation of medical treatments
|
2 and 3 years post-surgery
|
|
Changes in obesity-related medical comorbidities - T2DM
Time Frame: 2 and 3 years post-surgery
|
Remission of T2DM (normalization of lab values discontinuation of medical treatments and remission of T2DM/normalization of lab values)
|
2 and 3 years post-surgery
|
|
Changes in eating pathology - Emotional Eating
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the Emotional Eating Scale (EES).
The EES is a 25-item self-report measure that assesses the tendency to cope with negative affect by eating.
Respondents are presented with 25 emotions and are asked to rate the strength of their urge to eat on a scale from 1 (no desire to eat) to 5 (an overwhelming urge to eat) when experiencing each of the emotions.
The total EES score is calculated as a sum of all 25 self-report answers.
The EES consists of 3 subscales reflecting anger/frustration, anxiety, and depression.
The EES subscale scores are calculated as a sum of all self-report answers of emotions that fall within the subscale categories.
|
1.25, 1.5, 2, and 3 years post-surgery
|
|
Changes in eating pathology - Binge Eating
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the Binge Eating Scale (BES).
The BES is a 16-item self-report measure that assesses the presence of binge eating behaviour indicative of an eating disorder.
It was devised specifically for use with obese individuals.
Respondents are asked to rate the way they feel about their eating behaviour from 1 (statements indicating they see no problem with their eating behaviour) to 4 (statements indicating they see a severe problem with their eating behaviour).
Scores on the BES range from 0 to 46 with the total score calculated as a sum of all 16 self-report answers.
Moderate and severe levels of binge eating correspond to cut-off scores of 18 and 27.
|
1.25, 1.5, 2, and 3 years post-surgery
|
|
Changes in eating pathology - Loss of Control
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the Loss of Control over Eating Scale (LOCES-Brief).
The LOCES-Brief is a 7-item self-report measure that assesses the behavioural and cognitive aspects of loss of control eating, which may occur even in the absence of objectively large eating binges.
Respondents are asked to rate the frequency with which they have experienced loss of control over eating over the last month on a scale ranging from 1 (never) to 5 (always).
Scores on the LOCES-Brief can range from 7 to 35 with the total score calculated as a sum of all 7 self-report answers.
|
1.25, 1.5, 2, and 3 years post-surgery
|
|
Changes in eating pathology - Depression
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the Patient Health Questionnaire (PHQ-9).
The PHQ-9 is a 9-item self-report measure of depression severity.
Respondents are asked to rate the frequency with which they have experienced depressive symptoms over the last two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day).
Scores on the PHQ-9 can range from 0 to 27 with the total score calculated as a sum of all 9 self-report answers.
Mild, moderate, moderately severe, and severe levels of depressive symptoms correspond to cut-off scores of 5, 10, 15, and 20 respectively.
|
1.25, 1.5, 2, and 3 years post-surgery
|
|
Changes in eating pathology - Quality of Life
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the EuroQol (EQ-5D-5L).
The EQ-5D-5L is a 25 item self-report measure of health-related quality of life.
The EQ-5D-5L covers the 5 domains of mobility, self-care, daily activities, pain/discomfort, and anxiety/depression.
Each domain consists of 5 statements ranging from "I have no problems" to "I am unable to/I have extreme problems".
Respondents are also asked to rate how good or bad their health is at the current point in time on a scale from 0 (worst health you can imagine) to 100 (best health you can imagine).
|
1.25, 1.5, 2, and 3 years post-surgery
|
|
Changes in eating pathology - Anxiety
Time Frame: 1.25, 1.5, 2, and 3 years post-surgery
|
Measured by the Generalized Anxiety Disorder Scale (GAD-7).
The GAD-7 is a 7-item self report measure of anxiety severity.
It was originally developed to diagnose generalized anxiety disorder, but it has also proved to be a good screening instrument for other disorders including panic disorder, social phobia, and post-traumatic stress disorder.
Respondents are asked to rate the frequency with which they have experienced anxiety symptoms over the last two weeks on a scale ranging from 0 (not at all) to 3 (nearly every day).
Scores on the GAD-7 can range from 0 to 21 with the total score calculated as a sum of all 7 self-report answers.
Mild, moderate, and severe levels of anxiety symptoms correspond to cut-off scores on 5, 10, and 15 respectively.
|
1.25, 1.5, 2, and 3 years post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sanjeev Sockalingam, MD, FRCPC, University of Toronto, University Health Network
- Study Director: Raed Hawa, MD, FRCPC, University of Toronto, University Health Network
- Study Director: Susan Wnuk, PhD, CPsych, University of Toronto, University Health Network
- Study Director: Timothy Jackson, MD, FRCPC, University of Toronto, University Health Network
- Study Director: Lorraine Lipscombe, MD, FRCPC, Women's College Hospital
- Study Director: Allan Okrainec, MD, FRCPC, University of Toronto, University Health Network
- Study Director: George Tomlinson, PhD, University of Toronto
- Study Director: David Urbach, MD, FRCPC, University of Toronto, University Health Network
- Principal Investigator: Stephanie Cassin, PhD, CPsych, Toronto Metropolitan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006 Nov;91(11):4223-31. doi: 10.1210/jc.2006-0557. Epub 2006 Sep 5.
- Meany G, Conceicao E, Mitchell JE. Binge eating, binge eating disorder and loss of control eating: effects on weight outcomes after bariatric surgery. Eur Eat Disord Rev. 2014 Mar;22(2):87-91. doi: 10.1002/erv.2273.
- Sheets CS, Peat CM, Berg KC, White EK, Bocchieri-Ricciardi L, Chen EY, Mitchell JE. Post-operative psychosocial predictors of outcome in bariatric surgery. Obes Surg. 2015 Feb;25(2):330-45. doi: 10.1007/s11695-014-1490-9.
- DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L, Restuccia N, Yuen S, Fisk M, Inabnet WB, Bessler M. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010 May-Jun;6(3):249-53. doi: 10.1016/j.soard.2009.09.019. Epub 2009 Oct 29.
- Sockalingam S, Leung SE, Ma C, Hawa R, Wnuk S, Dash S, Jackson T, Cassin SE. The Impact of Telephone-Based Cognitive Behavioral Therapy on Mental Health Distress and Disordered Eating Among Bariatric Surgery Patients During COVID-19: Preliminary Results from a Multisite Randomized Controlled Trial. Obes Surg. 2022 Jun;32(6):1884-1894. doi: 10.1007/s11695-022-05981-6. Epub 2022 Feb 25. Erratum In: Obes Surg. 2022 Mar 18;:
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2018
Primary Completion (Actual)
January 15, 2024
Study Completion (Actual)
January 15, 2024
Study Registration Dates
First Submitted
August 31, 2017
First Submitted That Met QC Criteria
October 16, 2017
First Posted (Actual)
October 20, 2017
Study Record Updates
Last Update Posted (Actual)
May 10, 2024
Last Update Submitted That Met QC Criteria
May 8, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-5655
- 376045 (Other Grant/Funding Number: Canadian Institutes of Health Research (CIHR))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data (IPD) will not be shared publicly in order to protect patient confidentiality.
Aggregate and anonymous data will be shared in peer reviewed journal articles and scientific presentations.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Telephone-Based CBT
-
Iowa City Veterans Affairs Medical CenterUS Department of Veterans AffairsCompletedVeterans | Persistent Post-surgical PainUnited States
-
University Health Network, TorontoCompletedObesity | Eating Disorder
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH); University of Maryland, College...CompletedDepression | HIV InfectionsUnited States
-
University Health Network, TorontoCompleted
-
The University of Hong KongChinese University of Hong KongRecruiting
-
University of CologneEli Lilly and CompanyCompletedAttention-Deficit/Hyperactivity DisorderGermany
-
University of British ColumbiaCompletedMajor Depressive Disorder (MDD)Canada
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDepression | Traumatic Brain InjuryUnited States
-
VA Office of Research and DevelopmentCompleted
-
The Hong Kong Polytechnic UniversityNot yet recruiting